Targeted Treatments of Lung Cancer: demystifying the science
Dr Vickers describes the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer.
Start: 09:00, 08 April 2019
End: 17:00, 08 April 2019
Event: Study day
She also explains the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK and ROS1 inhibitors, B-Raf inhibitors, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
Download the full programme and booking formTargeted Treatments for Lung Cancers 2019.pdf
The Royal Marsden Education and Conference Centre, Stewart’s Grove, SW3 6JJ